
The deal with Serum gives Aspen certainty on volumes, which will eventually more than cover an expected decline in revenues from its COVID vaccine contract with J&J, he said.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yzBWwRf
via
IFTTT
0 comments:
Post a Comment